Clinical Trial Update: Pilot Study of Ketamine Sedation for Aneurysmal Subarachnoid Hemorrhage [Phase 2, Phase 3]

View source ↗

Summary

A pilot study evaluating ketamine sedation for aneurysmal subarachnoid hemorrhage has been withdrawn from Phase 2/Phase 3 development.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage
• Subarachnoid Hemorrhage

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Jenna L Leclerc MD, PhD | Conditions: Subarachnoid Hemorrhage, Aneurysmal | Phase 2, Phase 3 | Status: WITHDRAWN